NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) 1981 NO. 345 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) 1981 NO. 345 - TABLE OF PROVISIONS 1. Commencement 2. Schedule 1 3. Schedule 2 4. Schedule 3 5. Schedule 5 SCHEDULE 1 SCHEDULE 2 SCHEDULE 3 SCHEDULE 4 1981 No. 345 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - REG 1 Commencement 1. These Regulations shall come into operation on 1 December 1981. 1981 No. 345 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - REG 2 Schedule 1 2. Schedule 1 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 1. 1981 No. 345 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - REG 3 Schedule 2 3. Schedule 2 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 2. 1981 No. 345 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - REG 4 Schedule 3 4. Schedule 3 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 3. 1981 No. 345 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - REG 5 Schedule 5 5. Schedule 5 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 4. 1981 No. 345 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - SCHEDULE 1 SCHEDULE 1 Regulation 2 AMENDMENTS OF SCHEDULE 1 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS 1. Omit item 507. 2. After item 639 insert the following item: "639A Neostigmine Methylsulphate". 3. After item 718 insert the following item: "718A Pentolinium Injection". 1981 No. 345 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - SCHEDULE 2 SCHEDULE 2 Regulation 3 AMENDMENTS OF SCHEDULE 2 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS 1. After item 82 insert the following item: "82A Dextran 70 . . . . . . . . . . . . . . Hypromellose 4500 with Dextran 70". 2. After item 98 insert the following item: "98A Dipivefrin Hydrochloride . . . . . . . -". 3. Omit item 143, substitute the following item: "143 Hypromellose 4500 . . . . . . . . . . . Dextran 70 with Hypromellose 4500". 4. Omit item 174. 5. Omit item 194. 6. After item 245 insert the following item: "245A Tri-potassium Di-citrato Bismuthate Complex . . . . . . . . . . . . . . . . . . . . . -". 1981 No. 345 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - SCHEDULE 3 SCHEDULE 3 Regulation 4 AMENDMENTS OF SCHEDULE 3 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS 1. After item 43 insert the following item: "43A Bromocriptine Mesylate". 2. After item 83 insert the following item: "83A Dextran 70". 3. After item 93 insert the following item: "93A Dipivefrin Hydrochloride". 4. After item 113 insert the following item: "113A Gliclazide". 5. After item 178 insert the following item: "178A Mianserin Hydrochloride". 6. Omit item 211. 7. After item 284 insert the following item: "284A Trimipramine". 8. After 285 insert the following item: "285ATri-potassium Di-citrato Bismuthate Complex". 1981 No. 345 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - SCHEDULE 4 SCHEDULE 4 Regulation 5 AMENDMENTS OF SCHEDULE 5 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS 1. After item 15 insert the following items: "15A Bromocriptine Mesylate, Tablets 2.5 mg With the written authority of the Permanent Head- Pathological hyperprolactinaemia where appropriate surgery or radiotherapy are not indicated or have already been used with incomplete resolution 15B Bromocriptine Mesylate, Capsules 10 mg . With the written authority of the Permanent Head- Acromegaly, prior to surgery or radiotherapy or where surgery or radiotherapy is inappropriate". 2. Omit item 37, substitute the following item: "Cholestyramine . . . . . . . . . . . . . . With the written authority of the Permanent Head- Bile salt malabsorption associated with ileal resection or proven ileal disease Pruritus associated with partial biliary obstruction not responding toother therapy Hypercholesterolaemia". 3. Omit item 39A, substitute the following item: "39A Clofibrate Capsules, B.P. . . . . . . . With the written authority of the Permanent Head- Hypertriglyceridaemia Hypercholesterolaemia 4. After item 43 insert the following item: "43A Codeine Phosphate, B.P. with Paracetamol, B.P. Tablets 8 mg-500 mg . . . . . . For pensioners only". 5. Omit item 44, substitute the following item: "44 Colestipol Hydrochloride . . . . . . . . With the written authority of the Permanent Head- Hypercholesterolaemia". 6. Omit item 109. 7. After item 110 insert the following item: "110A Mianserin Hydrochloride . . . . . . . With the written authority of the Permanent Head- Depressive illness in persons with cardiovascular disease". 8. Omit item 156, substitute the following item: "156 (1) Sodium Valproate Syrup Epilepsy". (2) Sodium Valproate Tablet 200 mg 9. After item 156 insert the following item: "156A Sodium Valproate Tablet 500 mg (enteric coated) . . . . . . . . . . . . . . . . With the written authority of the Permanent Head- Epilepsy in patients requiring more than 1 g of sodium valproate daily". 10. Omit item 160, substitute the following item: "160 Sulindac . . . . . . . . . . . . . . . With the written authority of the Permanent Head- Chronic rheumatoid arthritis not responding to other non-steroidal anti-inflammatory drugs (disregarding phenylbutazone) Chronic osteoarthritis not responding to other non-steroidal anti-inflammatory drugs (disregarding phenylbutazone)". 11. After 176 insert the following item: "176A Trimipramine . . . . . . . . . . . . . With the written authority of the Permanent Head- Endogenous depression where there is an inadequate response to not less than 100 mg of trimipramine daily". 12. After 177 insert the following item "177A Tri-potassium Di-citrato Bismuthate Complex . . . . . . . . . . . . . . . . . . . . . With the written authority of the Permanent Head- Duodenal ulcer confirmed by radiology, endoscopy or surgery Gastric ulcer confirmed by radiology, endoscopy, or surgery". - NOTES 1981 No. 345*1* NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS*2* (AMENDMENT) *1* Notified in the Commonwealth of Australia Gazette on 30 November 1981. *2* Statutory Rules 1960 No. 17 as amended to date. For previous amendments see Note 2 to Statutory Rules 1981 No. 52 and see also Statutory Rules 1981 Nos. 52, 212 and 218.